POU5F1 and lung carcinoma: In the context of lung cancer, cells exhibiting high levels of POU5F1 expression have been observed to display resistance towards conventional treatment methods, including cisplatin, etoposide, paclitaxel, and targeted therapy with gefitinib [8, 9].